Møller Janne, Altraja Alan, Sjåheim Tone, Rasmussen Finn, Madsen Line Bille, Bendstrup Elisabeth
Center for Rare Lung Diseases, Department of Respiratory Diseases and Allergy, Aarhus University Hospital, Aarhus, Denmark.
Department of Pulmonary Medicine, University of Tartu, Tartu, Estonia.
Eur Clin Respir J. 2021 Jun 10;8(1):1933878. doi: 10.1080/20018525.2021.1933878.
Idiopathic Non-Specific Interstitial Pneumonia (iNSIP) is a rare interstitial lung disease, diagnosed, by definition, on the basis of a multidisciplinary team discussion (MDD). Association with an autoimmune background has been suggested in iNSIP.
To test the feasibility of conducting a multinational MDD to review the diagnosis in iNSIP cases and to estimate the emergence of connective tissue disease (CTD) during follow-up.
Investigators from three expert centers (Denmark, Estonia and Norway) met and discussed cases of biopsy-proven iNSIP at an international MDD. The cases were previously diagnosed at a national level between 2004 and 2014. Based on clinical, radiographic and pathological data, the diagnosis of iNSIP was re-evaluated and a consensus diagnosis was made. Cases incompatible with iNSIP were excluded. Relevant data were registered comprising any development of CTD.
In total, 31 cases were discussed and 23 patients were included with a diagnosis of iNSIP. The mean follow-up time was 57 months. None of the patients developed CTD according to the rheumatologic criteria during the follow up period. Four patients (17.4%) met the criteria for interstitial pneumonia with autoimmune features.
We found that an international MDD was a feasible and valuable tool in the retrospective diagnostic evaluation of iNSIP. Diagnosis was changed in a statistically significant number of patients by our international MDD team. None of the patients developed CTD during follow-up.
特发性非特异性间质性肺炎(iNSIP)是一种罕见的间质性肺疾病,根据定义,其诊断需基于多学科团队讨论(MDD)。已有研究提示iNSIP与自身免疫背景有关。
检验开展跨国多学科团队讨论以复查iNSIP病例诊断并评估随访期间结缔组织病(CTD)发生情况的可行性。
来自三个专家中心(丹麦、爱沙尼亚和挪威)的研究人员齐聚一堂,在一次国际多学科团队讨论中对经活检证实的iNSIP病例进行讨论。这些病例此前于2004年至2014年在国家层面被诊断。基于临床、影像学和病理数据,对iNSIP的诊断进行重新评估并达成共识诊断。排除不符合iNSIP的病例。记录相关数据,包括CTD的任何进展情况。
总共讨论了31例病例,23例患者被确诊为iNSIP。平均随访时间为57个月。随访期间,根据风湿病学标准,没有患者发生CTD。4例患者(17.4%)符合具有自身免疫特征的间质性肺炎标准。
我们发现国际多学科团队讨论在iNSIP的回顾性诊断评估中是一种可行且有价值的工具。我们的国际多学科团队讨论使相当数量患者的诊断发生了具有统计学意义的改变。随访期间没有患者发生CTD。